News for Amedisys, Inc. (AMED.MX)

Comprehensive SWOT analysis based on Amedisys Inc's latest SEC 10-K filing.Financial overview highlights Amedisys Inc's position as a leading healthcare servic

Amedisys Inc (AMED), a leading healthcare services company, released its financial results for the fourth quarter and full year ending December 31, 2024, on Feb

Revenue: $598.1 million, slightly below the estimated $598.58 million.Net Loss: $20.4 million, impacted by merger-related expenses and a significant non-cash g

BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. ( AMED) today reported its financial results for the three-month period and year ended Dece

The Department of Justice has reportedly launched an investigation into UnitedHealth Group's Medicare billing practices, adding to the scrutiny the company is facing.

On December 31, 2024, Highbridge Capital Management LLC executed a significant transaction by acquiring 1,187,056 shares of Velo3D Inc (VLDX). This strategic mo

Amedisys Inc (AMED), a prominent provider of home health, hospice, and high-acuity care services, announced on February 3, 2025, the recognition of 47 employees

On December 31, 2024, Highbridge Capital Management LLC executed a notable stock transaction, acquiring 335,000 shares of A SPAC III Acquisition Corp. This acqu

UnitedHealth Group Incorporated UNH will release earnings results for its fourth quarter, before the opening bell on Thursday, Jan. 16, 2025. Analysts expect t...

Shares of Amedisys Inc (AMED) surged 4.48% in mid-day trading on Dec 27. The stock reached an intraday high of $90.00, before settling at $89.80, up from it

Amedisys and UnitedHealth extend their $3.3B merger deadline to 2025, amid DOJ scrutiny over competition concerns in the home health market.

Factbox-US deals blocked by regulators or facing intense scrutiny

UnitedHealth shares drop amid executive's death and public backlash

Multiple executives at UnitedHealthcare were under investigation by the Department of Justice for insider trading and fraud when CEO Brian Thompson was shot and killed Wednesday.

Shares of Amedisys Inc (AMED) fell 3.73% in mid-day trading on Dec 3. The stock reached an intraday low of $86.31, before recovering slightly to $87.84, dow

Factbox-US deals blocked by regulators or facing intense scrutiny

US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports

Amedisys is being acquired by UnitedHealth for $3.3B, pending DOJ approval. Learn why UNH and AMED stock are impacted by regulatory concerns and scrutiny.

Believes Enhabit’s Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified Independent Directors Believes...